The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

15 Mar 2023 16:35

RNS Number : 1195T
Redx Pharma plc
15 March 2023
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEUVONROVUOAAR

Date   Source Headline
27th Oct 20227:00 amRNSRedx to Present Poster at ASN Kidney Week
11th Oct 20227:00 amRNSFirst Patient Dosed in Phase 2a Trial for RXC007
3rd Oct 20227:00 amRNSRedx Presents RXC007 Preclinical and Phase 1 Data
29th Sep 20227:41 amRNSRedx to Present Poster on RXC007 at ICLAF
6th Sep 20227:00 amRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSRedx to Present at the ERS International Congress
5th Aug 202211:52 amRNSCompletion of Placing and Director/PDMR Dealings
3rd Aug 20221:43 pmRNSProposed Secondary Placing of Shares via ABB
26th Jul 20221:47 pmRNSExercise of Options, PDMR Dealing and TVR
11th Jul 20227:00 amRNSRedx to Present at Virtual Investor Forum
27th Jun 20227:00 amRNSEncouraging Data on Porcupine and ROCK Inhibitors
23rd Jun 20227:00 amRNSInterim Results for the Six Months Ended 31 March
20th Jun 20227:00 amRNSRedx to Present at the ECM Congress
16th Jun 20227:00 amRNSNotice of Interim Results
15th Jun 20227:00 amRNSPan-RAF Inhibitor to Enter Clinical Development
9th Jun 20224:34 pmRNSTR-1: Notification of major holdings
8th Jun 20221:28 pmRNSTR-1: Notification of major holdings
7th Jun 20228:11 amRNSAdmission of Placing Shares
6th Jun 202211:56 amRNSResults of General Meeting
30th May 20227:00 amRNSRedx Presents Poster on RXC004 at ASCO
25th May 20227:00 amRNSRedx to Present at Jefferies Healthcare Conference
20th May 20227:00 amRNSNew Grant of Options
19th May 20222:34 pmRNSNew Grant of Options
19th May 202212:14 pmRNSResult of Accelerated Bookbuild
18th May 20226:28 pmRNSLaunch of Placing via Accelerated Bookbuild
27th Apr 20223:00 pmRNSRedx to Present at ASCO
8th Apr 20226:00 pmRNSRedx Presents Encouraging RXC004 Preclinical Data
5th Apr 20227:00 amRNSCollaboration with the Garvan Institute
30th Mar 20227:00 amRNSNomination of Clinical Development Candidate
24th Mar 20227:00 amRNSRedx to Present at the AACR Annual Meeting
10th Mar 20227:00 amRNSRedx Presents Encouraging Phase 1 Data for RXC007
9th Mar 20227:00 amRNSBoard Committee Changes
8th Mar 202212:30 pmRNSResult of AGM
2nd Mar 20227:00 amRNSRedx to Present at Cowen Health Care Conference
28th Feb 20227:00 amRNSRedx to Present at ILD Summit 2022
11th Feb 20224:43 pmRNSNotice of AGM
28th Jan 20227:00 amRNSNew Grant of Share Options
27th Jan 20227:01 amRNSAppointment of Non-Executive Director
27th Jan 20227:00 amRNSFinal Audited Results and Operational Update
25th Jan 202212:00 pmRNSNotice of Preliminary Results
23rd Dec 20217:00 amRNSRedx to Receive Milestone Payment of $9m from AZ
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20212:06 pmRNSSecond Price Monitoring Extn
9th Dec 20212:00 pmRNSPrice Monitoring Extension
9th Dec 20217:00 amRNSRedx to receive milestone of $10m from Jazz
6th Dec 20217:00 amRNSRedx and Caris Life Sciences Announce Partnership
30th Nov 20217:00 amRNSRedx to Participate at Piper Sandler Conference
17th Nov 20217:00 amRNSRedx to Present at Jefferies London Conference
15th Nov 20217:00 amRNSFirst Patient Dosed in Phase 2 Trial of RXC004

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.